Published in BMC Fam Pract on August 23, 2013
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA (2000) 5.94
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2013) 5.57
Physician advice for smoking cessation. Cochrane Database Syst Rev (2008) 5.00
Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev (2011) 4.71
EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil (2009) 3.19
First-line drugs for hypertension. Cochrane Database Syst Rev (2009) 2.44
EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil (2010) 1.58
A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998. Eur J Cardiovasc Prev Rehabil (2005) 1.12
Predictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44 649 Austrian men and women. Eur J Cardiovasc Prev Rehabil (2005) 1.08
A lifestyle intervention to reduce Type 2 diabetes risk in Dutch primary care: 2.5-year results of a randomized controlled trial. Diabet Med (2012) 1.07
Evaluation of cardiovascular risk predicted by different SCORE equations: the Netherlands as an example. Eur J Cardiovasc Prev Rehabil (2010) 1.03
Assessment of cardiovascular risk in primary health care. Scand J Prim Health Care (2012) 0.96
Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality. Int J Cardiol (2009) 0.91
Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study. Scand J Prim Health Care (2010) 0.90
Randomized controlled trial on cardiovascular risk management by practice nurses supported by self-monitoring in primary care. BMC Fam Pract (2012) 0.89
Fewer deaths from cardiovascular disease than expected from the Systematic Coronary Risk Evaluation chart in a Swedish population. Eur J Cardiovasc Prev Rehabil (2009) 0.82
Cost-effectiveness of cardiovascular risk management by practice nurses in primary care. BMC Public Health (2013) 0.78
Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol (2005) 3.29
Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial. J Clin Nurs (2011) 2.94
Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care (2009) 2.90
Job satisfaction among general practitioners: a systematic literature review. Eur J Gen Pract (2006) 2.77
Manipulative therapy in addition to usual medical care for patients with shoulder dysfunction and pain: a randomized, controlled trial. Ann Intern Med (2004) 2.58
Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet (2002) 2.39
Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial. Hypertension (2007) 2.33
Effect of device-guided breathing exercises on blood pressure in hypertensive patients with type 2 diabetes mellitus: a randomized controlled trial. J Hypertens (2007) 2.26
Device-guided breathing as treatment for hypertension in type 2 diabetes mellitus: a randomized, double-blind, sham-controlled trial. JAMA Intern Med (2013) 2.16
Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation (2004) 1.98
The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol (2005) 1.88
Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol (2005) 1.82
Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care (2007) 1.73
Effect of an increased intake of alpha-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) study. Am J Clin Nutr (2002) 1.63
Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4). Diabetes Care (2008) 1.62
Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care (2007) 1.59
Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care (2006) 1.58
The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11). Br J Gen Pract (2010) 1.54
Prevalence and persistence of masked hypertension in treated hypertensive patients. Am J Hypertens (2007) 1.50
Prevalence of the white-coat effect at multiple visits before and during treatment. J Hypertens (2006) 1.48
Vascular thoracic outlet syndrome. Longer posterior rib stump causes poor outcome. Eur J Cardiothorac Surg (2006) 1.45
Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review. BMC Fam Pract (2012) 1.41
The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress. Cardiovasc Drugs Ther (2007) 1.41
Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care (2006) 1.40
Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study. Diabetes Technol Ther (2009) 1.38
Continuous intraperitoneal insulin infusion versus subcutaneous insulin therapy in the treatment of type 1 diabetes: effects on glycemic variability. Diabetes Technol Ther (2015) 1.38
Lower blood pressure associated with higher mortality in elderly diabetic patients (ZODIAC-12). Age Ageing (2010) 1.26
Health-related quality of life and mortality in a general and elderly population of patients with type 2 diabetes (ZODIAC-18). Diabetes Care (2010) 1.24
Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Eur J Heart Fail (2007) 1.20
Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 1.18
Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther (2006) 1.18
Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study. Eur Heart J (2009) 1.17
The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev (2002) 1.17
Back to basics in diagnosing diabetic polyneuropathy with the tuning fork! Diabetes Care (2005) 1.15
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol (2012) 1.14
Self-monitoring of blood glucose: the use of the first or the second drop of blood. Diabetes Care (2011) 1.12
Local differences in skin autofluorescence may not reflect similar differences in oxidative stress exposure. J Rheumatol (2013) 1.09
Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial. Diabetes Care (2009) 1.07
Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10). PLoS One (2009) 1.06
Preventing weight gain: one-year results of a randomized lifestyle intervention. Am J Prev Med (2009) 1.04
The optimal scheme of self blood pressure measurement as determined from ambulatory blood pressure recordings. J Hypertens (2006) 1.04
Perceived wellbeing of patients one year post stroke in general practice--recommendations for quality aftercare. BMC Neurol (2011) 1.03
Population prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in the Netherlands. Should asymptomatic persons be tested during population-based Chlamydia screening also for gonorrhoea or only if chlamydial infection is found? BMC Infect Dis (2006) 1.03
Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1. Eur J Pediatr (2002) 1.02
A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19). BMJ Open (2012) 1.01
Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors. Arthritis Res Ther (2008) 1.00
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). Diabetes Care (2013) 0.99
Randomised controlled trial of local corticosteroid injections for de Quervain's tenosynovitis in general practice. BMC Musculoskelet Disord (2009) 0.99
Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease. Arterioscler Thromb Vasc Biol (2012) 0.99
Is glycogen storage disease 1a associated with atherosclerosis? Eur J Pediatr (2002) 0.98
Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump. Langenbecks Arch Surg (2008) 0.98
Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products. Atherosclerosis (2007) 0.98
Lessons learned from a population-based chlamydia screening pilot. Int J STD AIDS (2006) 0.98
Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease. Eur J Clin Invest (2010) 0.98
Preventing weight gain by lifestyle intervention in a general practice setting: three-year results of a randomized controlled trial. Arch Intern Med (2011) 0.97
The effect of exercise counselling with feedback from a pedometer on fatigue in adult survivors of childhood cancer: a pilot study. Support Care Cancer (2008) 0.96
Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol (2014) 0.95
Skin color independent assessment of aging using skin autofluorescence. Opt Express (2010) 0.95
Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study. Arterioscler Thromb Vasc Biol (2013) 0.95
Clinical and prognostic value of advanced glycation end-products in chronic heart failure. Eur Heart J (2007) 0.95
Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. Diabetes Care (2003) 0.95
Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques. BMC Nephrol (2012) 0.93
Dermal factors influencing measurement of skin autofluorescence. Diabetes Technol Ther (2011) 0.92
Health-related quality of life, treatment satisfaction, and costs associated with intraperitoneal versus subcutaneous insulin administration in type 1 diabetes: a randomized controlled trial. Diabetes Care (2010) 0.92
Identification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima-media thickness and coronary artery disease risk. Circ Cardiovasc Genet (2012) 0.92
The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13). PLoS One (2009) 0.92
Increased intima-media thickness after early-onset preeclampsia. Obstet Gynecol (2006) 0.92
Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease. Arthritis Res Ther (2011) 0.91
Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial). J Hypertens (2004) 0.91
Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease. Ann N Y Acad Sci (2005) 0.91
Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer. Eur J Cancer (2011) 0.91
AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis. Autoimmunity (2009) 0.91
AGEs, autofluorescence and renal function. Nephrol Dial Transplant (2008) 0.91
Randomised controlled trial of local corticosteroid injections for carpal tunnel syndrome in general practice. BMC Fam Pract (2010) 0.90
Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients. J Card Fail (2008) 0.90
Endothelial damage in long-term survivors of childhood cancer. J Clin Oncol (2013) 0.89
Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis. Am J Kidney Dis (2008) 0.89
Care for patients with severe mental illness: the general practitioner's role perspective. BMC Fam Pract (2009) 0.89
Randomized controlled trial on cardiovascular risk management by practice nurses supported by self-monitoring in primary care. BMC Fam Pract (2012) 0.89
Effect of device-guided breathing exercises on blood pressure in patients with hypertension: a randomized controlled trial. Blood Press (2009) 0.88
Care provided by general practitioners to patients with psychotic disorders: a cohort study. BMC Fam Pract (2010) 0.88
Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus. Atherosclerosis (2009) 0.88
Endothelial dysfunction in patients with coronary artery disease: a comparison of three frequently reported tests. J Investig Med (2002) 0.88
Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review. Clin Chem Lab Med (2014) 0.88
Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40). BMC Endocr Disord (2014) 0.87
Assessment of patient's experiences across the interface between primary and secondary care: Consumer Quality Index Continuum of care. Patient Educ Couns (2009) 0.87
Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events. Clin Chem (2011) 0.85
The care provided by general practitioners for persistent depression. Eur Psychiatry (2005) 0.85
Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus. Atherosclerosis (2011) 0.85
Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy. PLoS One (2012) 0.85
A model for post-occlusive reactive hyperemia as measured with laser-Doppler perfusion monitoring. IEEE Trans Biomed Eng (2005) 0.84
Management of Chlamydia cases and their partners: results from a home-based screening program organized by municipal public health services with referral to regular health care. Sex Transm Dis (2005) 0.84
Abnormal endothelium-dependent microvascular reactivity in recently preeclamptic women. Obstet Gynecol (2005) 0.84